CropLogic snares Oregon industrial hemp growers licence
Published 18-MAR-2019 14:01 P.M.
|
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
CropLogic Ltd’s (ASX:CLI) wholly owned Oregonian subsidiary LogicalCropping LLC has been issued a registered industrial hemp growers licence by the Oregon Department of Agriculture, a development that has seen its shares soar in morning trading.
The company’s shares hit a high of 2.0 cents, up 25% on Friday’s closing price.
It isn’t surprising to see such a strong rally given that this makes the company one of the first ASX listed players in the sector with a US hemp growers license.
Management expects to be able to produce between 80,000 kilograms and 150,000 kilograms of hemp biomass from the September 2019 harvest.
As mentioned last week, the company has a distinct advantage over many of its peers, having signed a three-year lease for a 150 hectare trial farm in Oregon, a premier region for the industrial hemp industry as it is amongst a handful of US states that legalised the production of the commodity some years prior to the passing of the Farm Bill in late 2018.
CropLogic licensed to grow and sell
Not only is CropLogic now legally permitted to grow industrial hemp in Oregon for this upcoming 2019 growing season, it can now generate income from selling its crop.
Harvesting will commence September 2019, and heralding this milestone event for the group, chief executive James Cooper-Jones said, “The licence permits CropLogic to produce and sell industrial hemp this season and potentially participate in the exceptional returns CropLogic has observed from other growers in Oregon.
“CropLogic is very excited about this significant milestone in its strategy to crop 150 acres of industrial hemp this season.”
Consumer demand for products that contain the therapeutic products of CBD (cannabidiol), a derivative of industrial hemp, has seen a significant increase in demand.
This follows the 2018 US federal Farm Bill signed into law by President Trump in December 2018, which legalised production federally and further legitimising and simplifying the production and commercialisation of industrial hemp and CBD in the US.”
Agronomy and agtech technologies on display
Managing the 150 acre trial farm in the highly productive Deschutes County will also allow CropLogic to demonstrate its agronomy and digital agtech technologies, particularly CropLogic realTime, which will be used to optimise yields.
CropLogic is working through a series of milestones for cropping of industrial hemp, including developing farm plans and preparations around this property.
“However, similar acreage producing hemp biomass of between 180,000 pounds to 337,500 pounds (81,647kg to 153,087kg) has been observed.
“The price for hemp biomass varies between grade and variety, but prices of US$35 to US$45 per pound were reported in CropLogic’s recent investigations into the industry.”
Based on the midpoint of similar acreage production which is in the order of 260,000 pounds and a mid-range price of US$40 per pound, this would generate income of US$10.4 million.
With the Australian dollar hovering in the vicinity of US$0.71, this equates to A$14.6 million.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
